Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.04. | hVIVO PLC - Annual Report & Notice of AGM | - | RNS | ||
09.04. | hVIVO swings to profit and commences annual dividends as outlook rosy | 1 | Alliance News | ||
09.04. | Hvivo unveils record results and bullish growth targets | 1 | Sharecast | ||
09.04. | hVIVO reports higher profits and revenues for 2023 | 3 | RTE.ie | ||
09.04. | hVIVO PLC - Final results | 1 | RNS | ||
27.03. | hVIVO PLC - Notice of Results | - | RNS | ||
22.03. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
14.03. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
16.02. | hVIVO directors sell 29 million shares, Greencore director buys on positive forecast | Director Deals | 6 | Shares | ||
15.02. | hVIVO PLC - Long Term Incentive Plan / PDMR Notification | 1 | RNS | ||
14.02. | IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares | 2 | Alliance News | ||
14.02. | hVIVO PLC - Result of Secondary Placing | - | RNS | ||
14.02. | IN BRIEF: hVIVO directors to sell total of 14 million shares | 2 | Alliance News | ||
14.02. | hVIVO PLC - Proposed Secondary Placing of Ordinary Shares | - | RNS | ||
02.02. | hVIVO PLC - Holding(s) in Company | 2 | RNS | ||
30.01. | hVIVO shares up after "record year" across all metrics | 1 | Alliance News | ||
30.01. | Life sciences firm hVIVO has record year as Canary Wharf site set for completion | 1 | City A.M. | ||
30.01. | hVIVO PLC - Trading update | - | RNS | ||
08.01. | hVIVO PLC - Broker change | 1 | RNS | ||
02.01. | hVIVO inks GBP6.3 million deal to test common cold treatment | 1 | Alliance News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 99,65 | -0,35 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
INTUITIVE SURGICAL | 360,45 | +1,31 % | Verhaltene Kauflaune bei Intuitive Surgical-Aktie (355,3540 €) | Wenig Kursbewegung gegenwärtig bei der Intuitive Surgical-Aktie . Die Aktie notiert zur Stunde bei 382,83 US-Dollar. Kaum auffällig ist aktuell am Aktienmarkt der Kurs von Intuitive Surgical. Das Wertpapier... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,854 | -0,96 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Private Placement Financing of up to $18 Million | ||
BAXTER | 33,700 | -0,60 % | Baxter-Aktie: Kurs steigt nur geringfügig (37,7621 €) | Am US-amerikanischen Aktienmarkt ist die Aktie von Baxter gegenwärtig unauffällig. Die Aktie notiert derzeit bei 40,45 US-Dollar. Einen geringen Wertanstieg von 0,20 Prozent zeigt die Kurstafel für... ► Artikel lesen | |
SPINEWAY | 0,594 | -13,91 % | SPINEWAY: Growth of 28% of 2024 first quarter revenue | Press release Ecully, April 16, 2024 - 8 p.m. First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter In thousands of euros20242023Change 2023/2022Q1 revenue3... ► Artikel lesen | |
CO-DIAGNOSTICS | 1,160 | -1,69 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
ASENSUS SURGICAL | 0,249 | +9,32 % | Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024 | ||
ORGANON | 19,210 | 0,00 % | Organon Reports Results for the First Quarter Ended March 31, 2024 | JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2024.
"We entered this year with a clear focus: to deliver our 2024 financial... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,308 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve changes auditor to MS Partners | ||
REWALK ROBOTICS | 4,675 | 0,00 % | ReWalk Robotics Ltd. (DBA Lifeward): Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate | Collaboration with CMS on final payment rate focuses on commercial transaction values for the latest generation of ReWalk Exoskeleton CMS indicates that recently issued fee schedule which omitted... ► Artikel lesen | |
JD HEALTH | 3,600 | -2,17 % | JD Health-Aktie mit Kursverlusten (3,50 €) | Im Minus liegt zur Stunde die JD Health-Aktie . Das Wertpapier notiert gegenwärtig bei 3,50 Euro. Ein Verlust von 3,31 Prozent steht gegenwärtig für die Aktie von JD Health zu Buche. Die Aktie verbilligte... ► Artikel lesen | |
EKSO BIONICS | 1,215 | -2,02 % | Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript | ||
BIOCEPT | 6,800 | 0,00 % | NSE - BIOCEPT INC - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
IMUNON | 1,260 | +2,44 % | Imunon, Inc.: IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024 |